Found: 53
Select item for more details and to access through your institution.
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091
- By:
- Publication type:
- Article
Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2459, doi. 10.1111/dom.14832
- By:
- Publication type:
- Article
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2707, doi. 10.1111/dom.14525
- By:
- Publication type:
- Article
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386
- By:
- Publication type:
- Article
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1420, doi. 10.1111/dom.14351
- By:
- Publication type:
- Article
The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 763, doi. 10.1111/dom.14281
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 382, doi. 10.1111/dom.14226
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 252, doi. 10.1111/dom.14197
- By:
- Publication type:
- Article
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1753, doi. 10.1111/dom.14091
- By:
- Publication type:
- Article
Dedicated kidney disease‐focused outcome trials with sodium‐glucose cotransporter‐2 inhibitors: Lessons from CREDENCE and expectations from DAPA‐HF, DAPA‐CKD, and EMPA‐KIDNEY.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, p. 46, doi. 10.1111/dom.13987
- By:
- Publication type:
- Article
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1237, doi. 10.1111/dom.13648
- By:
- Publication type:
- Article
Muscle strength, mobility, quality of life and falls in patients on maintenance haemodialysis: A prospective study.
- Published in:
- Nephrology, 2017, v. 22, n. 3, p. 220, doi. 10.1111/nep.12749
- By:
- Publication type:
- Article
Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': The ACTIVE Dialysis Study.
- Published in:
- Nephrology, 2015, v. 20, n. 4, p. 257, doi. 10.1111/nep.12385
- By:
- Publication type:
- Article
Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF‐6D utility and mental component SF‐36 quality of life: An AusDiab analysis.
- Published in:
- Nephrology, 2019, v. 24, n. 6, p. 605, doi. 10.1111/nep.13445
- By:
- Publication type:
- Article
133-LB: Canagliflozin Improves Cardiovascular and Renal Outcomes across Broad Geographic Regions: Results from CREDENCE.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-133-LB
- By:
- Publication type:
- Article
131-LB: The Impact of Canagliflozin on the Risk of Neuropathy Events: Results from the CREDENCE Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-131-LB
- By:
- Publication type:
- Article
129-LB: Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex in the CREDENCE Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-129-LB
- By:
- Publication type:
- Article
27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-27-OR
- By:
- Publication type:
- Article
26-OR: Acute Declines in EGFR during Treatment with Canagliflozin and Its Implications for Clinical Practice: Insights from CREDENCE.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-26-OR
- By:
- Publication type:
- Article
1098-P: Biomarkers of Tubular Injury and Effects of Canagliflozin in the CANVAS Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1098-P
- By:
- Publication type:
- Article
1130-P: Temporal Trends in Pharmacotherapy for Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1130-P
- By:
- Publication type:
- Article
1129-P: Association between the Intensity of Diabetes Therapy, Achieved HbA1c, and Persistence.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1129-P
- By:
- Publication type:
- Article
Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cardiovascular adaptations associated with exercise in patients on hemodialysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
SGLT2 inhibitors and finerenone: one or the other or both?
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1209, doi. 10.1093/ndt/gfac046
- By:
- Publication type:
- Article
Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, p. i48, doi. 10.1093/ndt/gfz252
- By:
- Publication type:
- Article
Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials.
- Published in:
- Nephrology Dialysis Transplantation, 2013, v. 28, n. 12, p. 3127, doi. 10.1093/ndt/gft501
- By:
- Publication type:
- Article
Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials.
- Published in:
- Nephrology Dialysis Transplantation, 2013, v. 28, n. 11, p. 2875, doi. 10.1093/ndt/gft406
- By:
- Publication type:
- Article
mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): the question remains open.
- Published in:
- Nephrology Dialysis Transplantation, 2013, v. 28, n. 2, p. 242, doi. 10.1093/ndt/gfs519
- By:
- Publication type:
- Article
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2023, p. 1, doi. 10.1177/20543581231217857
- By:
- Publication type:
- Article
Effects of Hemodiafiltration and High Flux Hemodialysis on Nerve Excitability in End-Stage Kidney Disease.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059055
- By:
- Publication type:
- Article
Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation.
- Published in:
- Kidney International, 2009, v. 76, n. 6, p. 659, doi. 10.1038/ki.2009.236
- By:
- Publication type:
- Article
A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study.
- Published in:
- Blood Purification, 2020, v. 49, n. 4, p. 468, doi. 10.1159/000505567
- By:
- Publication type:
- Article
Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial.
- Published in:
- Journal of Diabetes Research, 2022, p. 1, doi. 10.1155/2022/9998891
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1482, doi. 10.1002/ehf2.13236
- By:
- Publication type:
- Article
Risk factors for incident kidney disease in older adults: an Australian prospective population‐based study.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 5, p. 808, doi. 10.1111/imj.15074
- By:
- Publication type:
- Article
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
- Published in:
- Annals of Internal Medicine, 2019, v. 171, n. 3, p. 181, doi. 10.7326/M19-0087
- By:
- Publication type:
- Article
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 11, p. 2059, doi. 10.1093/ckj/sfad188
- By:
- Publication type:
- Article
Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South‐East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 1, p. 54, doi. 10.1111/jdi.13624
- By:
- Publication type:
- Article
Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0213192
- By:
- Publication type:
- Article
Photopheresis therapy for problematic renal allograft rejection.
- Published in:
- Journal of Clinical Apheresis, 2009, v. 24, n. 4, p. 161, doi. 10.1002/jca.20199
- By:
- Publication type:
- Article
Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2021, v. 4, n. 3, p. 1, doi. 10.1002/edm2.247
- By:
- Publication type:
- Article
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 13, p. 1, doi. 10.1161/JAHA.122.028516
- By:
- Publication type:
- Article
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4891, doi. 10.1093/eurheartj/ehab497
- By:
- Publication type:
- Article